Cancers (Feb 2022)

A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective

  • Tomas Pitra,
  • Kristyna Pivovarcikova,
  • Reza Alaghehbandan,
  • Adriena Bartos Vesela,
  • Radek Tupy,
  • Milan Hora,
  • Ondrej Hes

DOI
https://doi.org/10.3390/cancers14030831
Journal volume & issue
Vol. 14, no. 3
p. 831

Abstract

Read online

Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal tumor with indolent clinical behavior. In most of cases, it is an incidental finding during the examination of other health issues. The true incidence rate is estimated to be between 1.5% and 4% of all RCCs. These lesions are classified according to the Bosniak classification as Bosniak category III. There is a wide spectrum of diagnostic tools that can be utilized in the identification of this tumor, such as computed tomography (CT), magnetic resonance (MRI) or contrast-enhanced ultrasonography (CEUS). Management choices of these lesions range from conservative approaches, such as clinical follow-up, to surgery. Minimally invasive techniques (i.e., robotic surgery and laparoscopy) are preferred, with an emphasis on nephron sparing surgery, if clinically feasible.

Keywords